53 related articles for article (PubMed ID: 9040055)
1. Plasma levels of the monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 are elevated in patients with acute myocardial infarction.
Matsumori A; Furukawa Y; Hashimoto T; Yoshida A; Ono K; Shioi T; Okada M; Iwasaki A; Nishio R; Matsushima K; Sasayama S
J Mol Cell Cardiol; 1997 Jan; 29(1):419-23. PubMed ID: 9040055
[TBL] [Abstract][Full Text] [Related]
2. Monocyte chemoattractant protein 1 is a prognostic marker in ANCA-associated small vessel vasculitis.
Ohlsson S; Bakoush O; Tencer J; Torffvit O; Segelmark M
Mediators Inflamm; 2009; 2009():584916. PubMed ID: 19587833
[TBL] [Abstract][Full Text] [Related]
3. A theoretical timeline for myocardial infarction: immunohistochemical evaluation and western blot quantification for Interleukin-15 and Monocyte chemotactic protein-1 as very early markers.
Turillazzi E; Di Paolo M; Neri M; Riezzo I; Fineschi V
J Transl Med; 2014 Jul; 12():188. PubMed ID: 24989171
[TBL] [Abstract][Full Text] [Related]
4. Predicting chemotherapy toxicity in multiple myeloma: the prognostic value of pre-treatment serum cytokine levels of interleukin-6, interleukin-8, monocyte chemoattractant protein-1, and vascular endothelial growth factor.
Mielnik M; Podgajna-Mielnik M; Szudy-Szczyrek A; Homa-Mlak I; Mlak R; Gorący A; Hus M
Front Immunol; 2024; 15():1377546. PubMed ID: 38846938
[TBL] [Abstract][Full Text] [Related]
5. Assessing the variability and the role of inflammatory cytokines and monocyte chemoattractant protein-1 (MCP-1) in predicting stroke among hypertensives: A case-control study.
Sakyi SA; Opoku AS; Amoani B; Afranie BO; Kwarteng A; Ephriam RD; Opoku S; Senu E; Aidoo E; Sarfo FS
Dialogues Health; 2022 Dec; 1():100086. PubMed ID: 38515909
[TBL] [Abstract][Full Text] [Related]
6. Hydroxychloroquine Attenuates Myocardial Ischemic and Post-Ischemic Reperfusion Injury by Inhibiting the Toll-Like Receptor 9 - Type I Interferon Pathway.
Marsh KM; Rastogi R; Zhang A; Wu D; Kron IL; Yang Z
Cardiol Cardiovasc Med; 2022; 6(4):416-423. PubMed ID: 36081846
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory Mediators in Atherosclerotic Vascular Remodeling.
Evans BR; Yerly A; van der Vorst EPC; Baumgartner I; Bernhard SM; Schindewolf M; Döring Y
Front Cardiovasc Med; 2022; 9():868934. PubMed ID: 35600479
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of MCP-1 Chemokine in the Monitoring of Patients with Coronary Artery Disease Subjected to Intensive Dietary Intervention: A Pilot Study.
Makarewicz-Wujec M; Henzel J; Kępka C; Kruk M; Wardziak Ł; Trochimiuk P; Parzonko A; Dzielińska Z; Demkow M; Kozłowska-Wojciechowska M
Nutrients; 2021 Aug; 13(9):. PubMed ID: 34578925
[TBL] [Abstract][Full Text] [Related]
9. 5-LO-derived LTB4 plays a key role in MCP-1 expression in HMGB1-exposed VSMCs via a BLTR1 signaling axis.
Choi JM; Baek SE; Kim JO; Jeon EY; Jang EJ; Kim CD
Sci Rep; 2021 May; 11(1):11100. PubMed ID: 34045591
[TBL] [Abstract][Full Text] [Related]
10. The Role of CXCR3 and Associated Chemokines in the Development of Atherosclerosis and During Myocardial Infarction.
Szentes V; Gazdag M; Szokodi I; Dézsi CA
Front Immunol; 2018; 9():1932. PubMed ID: 30210493
[TBL] [Abstract][Full Text] [Related]
11. Association of circulating levels of RANTES and -403G/A promoter polymorphism to acute heart failure after STEMI and to cardiogenic shock.
Lipkova J; Parenica J; Duris K; Helanova K; Tomandl J; Kubkova L; Vasku A; Goldbergova Pavkova M
Clin Exp Med; 2015 Aug; 15(3):405-14. PubMed ID: 24934326
[TBL] [Abstract][Full Text] [Related]
12. Stromal derived factor 1α: a chemokine that delivers a two-pronged defence of the myocardium.
Bromage DI; Davidson SM; Yellon DM
Pharmacol Ther; 2014 Sep; 143(3):305-15. PubMed ID: 24704323
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Janus activated kinase-3 protects against myocardial ischemia and reperfusion injury in mice.
Oh YB; Ahn M; Lee SM; Koh HW; Lee SH; Kim SH; Park BH
Exp Mol Med; 2013 May; 45(5):e23. PubMed ID: 23680658
[TBL] [Abstract][Full Text] [Related]
14. Relationships between serum MCP-1 and subclinical kidney disease: African American-Diabetes Heart Study.
Murea M; Register TC; Divers J; Bowden DW; Carr JJ; Hightower CR; Xu J; Smith SC; Hruska KA; Langefeld CD; Freedman BI
BMC Nephrol; 2012 Nov; 13():148. PubMed ID: 23151275
[TBL] [Abstract][Full Text] [Related]
15. Myocardial production and release of MCP-1 and SDF-1 following myocardial infarction: differences between mice and man.
Boyle AJ; Yeghiazarians Y; Shih H; Hwang J; Ye J; Sievers R; Zheng D; Palasubramaniam J; Palasubramaniam D; Karschimkus C; Whitbourn R; Jenkins A; Wilson AM
J Transl Med; 2011 Sep; 9():150. PubMed ID: 21910857
[TBL] [Abstract][Full Text] [Related]
16. High white blood cell count and low estimated glomerular filtration rate are independently associated with serum level of monocyte chemoattractant protein-1 in a general population.
Fukami A; Yamagishi S; Adachi H; Matsui T; Yoshikawa K; Ogata K; Kasahara A; Tsukagawa E; Yokoi K; Imaizumi T
Clin Cardiol; 2011 Mar; 34(3):189-94. PubMed ID: 21337348
[TBL] [Abstract][Full Text] [Related]
17. Increased levels of CRP and MCP-1 are associated with previously unknown abnormal glucose regulation in patients with acute STEMI: a cohort study.
Knudsen EC; Seljeflot I; Michael A; Eritsland J; Mangschau A; Müller C; Arnesen H; Andersen GØ
Cardiovasc Diabetol; 2010 Sep; 9():47. PubMed ID: 20809989
[TBL] [Abstract][Full Text] [Related]
18. Systemic response of peripheral blood leukocytes and their phagocytic activity during acute myocardial infarction.
Djurdjevic PM; Arsenijevic NN; Baskic DD; Djukic AL; Popovic S; Samardzic G
Exp Clin Cardiol; 2001; 6(3):159-66. PubMed ID: 20428453
[TBL] [Abstract][Full Text] [Related]
19. Monocyte chemoattractant protein-1/CCL2 as a biomarker in acute coronary syndromes.
Gonzalez-Quesada C; Frangogiannis NG
Curr Atheroscler Rep; 2009 Mar; 11(2):131-8. PubMed ID: 19228487
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological activation of the prostaglandin E2 receptor EP4 improves cardiac function after myocardial ischaemia/reperfusion injury.
Hishikari K; Suzuki J; Ogawa M; Isobe K; Takahashi T; Onishi M; Takayama K; Isobe M
Cardiovasc Res; 2009 Jan; 81(1):123-32. PubMed ID: 18805784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
